Latest Whitepapers
Whitepaper
Automated Epitope Binning in a Single Assay
Binding affinity is a significant factor to consider. However, relying solely on affinity can be problematic, as the highest affinity mAbs may not exhibit optimal activity. To ensure the best lead candidates, it is crucial to consider factors like specificity, selectivity and biological relevance.
Whitepaper
Heralding a New Era of RNA Therapeutics
This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.
Whitepaper
Discover Custom Antibody and Immunoassay Development Solutions
This whitepaper explores the key steps in the antibody development process and highlights how partnership with an expert manufacturing service provider can help to simplify and expedite your workflow.
Whitepaper
Detect Low Abundance Biomarkers in Murine Models
In this interview, delve into the significance of measuring immune mediators with high sensitivity, revolutionizing our understanding of disease dynamics.
Whitepaper
The Transformative Potential of Metabolomics in Complex Chronic Disease Research
Genomics, proteomics and microbiomics are all useful tools in complex disease research. However, using these tools alone can risk critical knowledge gaps and leave researchers struggling to predict disease outcomes.
Whitepaper
Illuminating Immunology With Spectral Flow Cytometry
Flow cytometry is a core technique in many immunology labs.. However, extensive immunophenotyping panels can result in overlapping emission peaks, time-consuming compensation and complex data analysis.
Whitepaper
Discover Single-Use Fermenters for Biopharmaceutical Production
Single-use fermenters (SUFs) use disposable sterile plastic bags that don’t require the traditional high-intensity preparation of SS bioreactors, which are expensive and time-consuming processes.
Whitepaper
Antibody–Drug Conjugates: A Novel Paradigm for Cancer Therapy
This whitepaper highlights the key molecular components of ADCs and the challenges and opportunities for their future development.
Whitepaper
The Power of mRNA in Accelerating Therapeutic Development
mRNA-based therapies, from infectious disease vaccines to genetic disorder treatments, are gaining traction. However, mRNA purification methods must evolve beyond traditional precipitation techniques to meet the demands of large-scale therapeutic production.
Whitepaper
A Translational Perspective – Biacore Systems in Discovery and Early-Stage Development
For a smooth molecule journey from benchtop to clinic you need to make the most informed candidate selection and reduce the risk of failure and complications during development. Our BiacoreTM systems support informed decision-making during the lead candidate selection process. Its technology delivers valuable insights into developability such as manufacturability and safety.
Advertisement